Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.

Regeneron Pharmaceuticals, Inc. reported a stellar quarter, with earnings hitting $12.89 per share, crushing the $8.43 expected by analysts. Citizens Financial Group Inc. RI reduced its stake in the ...

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals is conducting a ...

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

One of the companies mentioned in the letter is Regeneron Pharmaceuticals Inc. (NASDAQ:REGN). Regeneron Pharmaceuticals Inc. ...

The biotechnology industry is split between two very different types of companies. On one side are the large, blue-chip leaders like Amgen Inc. (ticker: AMGN), Gilead Sciences Inc.

Swiss National Bank trimmed its stake in Regeneron Pharmaceuticals, Inc. by a modest 0.5%. Despite this, Regeneron's share ...

Sanofi (SNY) halts shipments of cholesterol drug Praluent developed with Regeneron (REGN) due to availability issues. Read ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is one of the top most undervalued biotech stocks to buy now. Guggenheim ...

"Speculation swirls after Trump's mysterious exit from press conference fuels health concerns. What happened on July 31? #TrumpHealthScare" ...

Sanofi said on Tuesday it had stopped supplying Praluent, a popular cholesterol drug jointly developed by the French ...

Moving on, Regeneron’s second-quarter report was largely positive. Total revenues of $3.68 billion (up 4% YoY) beat analyst ...